Patents by Inventor Wallace Yokoyama

Wallace Yokoyama has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110071107
    Abstract: Water-soluble cellulose derivatives are useful in methods of preventing or treating metabolic syndrome or a symptom or condition associated with the metabolic syndrome in an individual, and in particular for preventing or treating one or more of the symptoms a) hypertension, b) proinflammatory or inflammation state and c) prothrombotic state.
    Type: Application
    Filed: October 18, 2007
    Publication date: March 24, 2011
    Inventors: Stephanie K Lynch, Maciej Turowski, Wallace Yokoyama, Yun-Jeong Hong, Jerry R. Conklin, Shao-Ching Hung, Scott A. Young
  • Publication number: 20100247664
    Abstract: Water-insoluble cellulose derivatives such as ethyl cellulose can be used to treat or prevent metabolic syndrome and/or one of the abnormalities of metabolic syndrome.
    Type: Application
    Filed: October 18, 2007
    Publication date: September 30, 2010
    Inventors: Stephanie K. Lynch, Wallace Yokoyama, Maciej Turowski, Jerry R. Conklin
  • Publication number: 20090093441
    Abstract: A water-insoluble cellulose derivative, such as ethyl cellulose is useful for preventing or reducing oxidative stress or oxidative cell injury in tissues of an animal and in particular for influencing the level Stearoyl-CoA Desaturase-1 (SCD1) gene expression or ATP synthase mitochondrial F1 complex assembly factor 1 (ATPAF1) gene expression in non-adipose tissues of the animal.
    Type: Application
    Filed: October 18, 2007
    Publication date: April 9, 2009
    Inventors: Stephanie K. Lynch, Maciej Turowski, Wallace Yokoyama
  • Publication number: 20090093442
    Abstract: Water-soluble cellulose derivatives are useful in methods of preventing or treating metabolic syndrome or a symptom or condition associated with the metabolic syndrome in an individual, and in particular for preventing or treating one or more of the symptoms a) hypertension, b) proinflammatory or inflammation state and c) prothrombotic state.
    Type: Application
    Filed: October 18, 2007
    Publication date: April 9, 2009
    Inventors: Stephanie K. Lynch, Maciej Turowski, Wallace Yokoyama, Yun-Jeong Hong, Jerry R. Conklin, Shao-Ching Hung, Scott A. Young
  • Publication number: 20080176819
    Abstract: Water-insoluble cellulose derivatives such as ethyl cellulose can be used to treat or prevent metabolic syndrome and/or one of the abnormalities of metabolic syndrome.
    Type: Application
    Filed: October 18, 2007
    Publication date: July 24, 2008
    Inventors: Stephanie K. Lynch, Maciej Turowski, Wallace Yokoyama, Jerry R. Conklin
  • Publication number: 20070123490
    Abstract: A water-soluble cellulose derivative is useful for preventing or reducing oxidative stress or oxidative cell injury in tissues of an animal and in particular for regulating Stearoyl-CoA Desaturase-1 gene expression and/or ATPF1 gene expression in non-adipose tissues of the animal.
    Type: Application
    Filed: November 30, 2005
    Publication date: May 31, 2007
    Inventors: Wallace Yokoyama, Maciej Turowski, Qiming Shao, Stephanie Lynch
  • Publication number: 20060057231
    Abstract: Resveratrol, a stilbenoid antioxidant found in grapes, wine, peanuts and other berries, has been reported to have hypolipidemic properties. We investigated whether resveratrol and its three analogs (pterostilbene, piceatannol and resveratrol trimethyl ether) would activate the peroxisome proliferator-activated receptor alpha (PPAR?) isoform. This nuclear receptor is proposed to mediate the activity of lipid-lowering drugs such as the fibrates. The four stilbenes were evaluated along with ciprofibrate (positive control) at 1, 10, 100, 300 ?M concentrations, for the activation of endogenous PPAR? in H4IIEC3 cells. Cells were transfected with a peroxisome proliferator response element-AB (rat fatty acyl CoA ?-oxidase response element)—luciferase gene reporter construct. Of the four analogs, pterostilbene demonstrated the highest induction of PPAR? showing 7- and 9-14 fold increases in luciferase activity at 100 and 300 ?M, respectively, relative to control.
    Type: Application
    Filed: August 18, 2005
    Publication date: March 16, 2006
    Inventors: Agnes Rimando, Dennis Feller, Wallace Yokoyama